News + Filings Transactions
|
Lacey David L.
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/15/2023 | Arcus Biosciences, Inc. | RCUS | Grant | Stock Option (Right to Buy) | 19.5k | $19.60 | $382.2k | | 06/15/2023 |
| 06/15/2023 | Arcus Biosciences, Inc. | RCUS | Grant | Common Stock | 6.8k | $0.00 | $0 | | 06/15/2023 |
| 06/13/2023 | Atreca, Inc. | BCEL | Grant | Stock Option (right to buy) | 12k | $1.18 | $14.2k | | 06/13/2023 |
| 05/04/2023 | Nurix Therapeutics, Inc. | NRIX | Grant | Director Stock Option (right to buy) | 25k | $9.44 | $236k | | 05/04/2023 |
| 06/08/2022 | Atreca, Inc. | BCEL | Grant | Stock Option (right to buy) | 12k | $2.09 | $25.1k | | 06/08/2022 |
| 05/05/2022 | Nurix Therapeutics, Inc. | NRIX | Grant | Director Stock Option (right to buy) | 17.5k | $10.39 | $181.8k | | 05/05/2022 |
| 06/09/2021 | Atreca, Inc. | BCEL | Grant | Stock Option (right to buy) | 12k | $10.27 | $123.2k | | 06/09/2021 |
| 06/03/2021 | Arcus Biosciences, Inc. | RCUS | Grant | Common Stock | 3k | $0.00 | $0 | | 06/03/2021 |
| 06/03/2021 | Arcus Biosciences, Inc. | RCUS | Grant | Stock Option (Right to Buy) | 14.1k | $24.79 | $349.5k | | 06/03/2021 |
| 05/06/2021 | Nurix Therapeutics, Inc. | NRIX | Grant | Director Stock Option (right to buy) | 17.5k | $27.38 | $479.2k | | 05/06/2021 |
| 06/18/2020 | Unity Biotechnology, Inc. | UBX | Grant | Stock Option (Right to Buy) | 25k | $9.14 | $228.5k | | 06/18/2020 |
| 06/10/2020 | Atreca, Inc. | BCEL | Grant | Stock Option (right to buy) | 12k | $17.87 | $214.4k | | 06/10/2020 |
| 05/21/2020 | Arcus Biosciences, Inc. | RCUS | Grant | Stock Option (right to buy) | 50k | $36.34 | $1.8M | | 05/21/2020 |
| 06/20/2019 | Unity Biotechnology, Inc. | UBX | Grant | Stock Option (Right to Buy) | 25k | $9.00 | $225k | | 06/20/2019 |
|